syngo DynaPBV Body
Evaluate perfusion for personalized therapy
Preparatory Arteriography for Isolation of the Hepatic Arterial Bed Prior to Radioembolization Therapy - Supported by syngo DynaPBV Body
Courtesy of Bora Peynircioğlu, M.D.,
Associate Professor of Radiology, Department of Radiology, Hacettepe University Hospital, Ankara, Turkey
Transarterial Chemoembolization (TACE) in Multifocal Primary Liver Cancer - Supported by syngo DynaPBV Body
Courtesy of Philippe L. Pereira, M.D., PhD, EBIR, and Kristina Krüger,
Department of Radiology, Minimally Invasive Therapies and Nuclear Medicine,
SLK Clinics GmbH, Heilbronn, Germany
Protocols and Sequences
Transarterial chemoembolization of HCC using syngo DynaPBV Body
51-year-old male with Hep C. Hepatocellular BCLC stage A carcinoma (HCC), which is not amenable to radiofrequency (RF) ablation due to its proximity to the gall bladder. Patient is awaiting liver transplant and recommended for TACE treatment.
Scientific Talks and Publications
The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.